N/A
Completed N=164
Smoking Cessation After Hospitalization for a Cardiopulmonary Illness
Source: ClinicalTrials.gov NCT01791803 ↗Enrolled (actual)
164
Serious AEs
0.0%
Results posted
May 2017
Primary outcomePrimary: Abstinence From Smoking — 15; 7; 13; 10 percentage of participants
Summary
Smoking-related cardiopulmonary diseases account for a large number of hospital admissions. We investigated the efficacy of hypnotherapy as an aid to a counseling-based smoking cessation program in improving quit rates of hospitalized smoking patients at 12 and 26 weeks after hospital discharge. We compared outcomes with hospitalized patients who received more conventional therapy, namely nicotine replacement therapy, or patients who decided to quit on their own. We also compared smoking cessation rates at 12 and 26 weeks after hospitalization among patients admitted with a cardiac or a pulmonary diagnosis.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Abstinence From Smoking |
15; 7; 13; 10 | — |
| SECONDARY Smoking Cessation |
18; 11; 18; 0 | — |
| SECONDARY Smoking Abstinence Rate at 12 and 26 Weeks |
52.1; 20; 34; 20 | < 0.001 sig |
Eligibility Criteria
Inclusion Criteria
- Hospitalized patients with a Cardiopulmonary admission.
Exclusion Criteria
- Terminal illness, history of Serious Psychiatric illness or substance abuse, Pregnancy, Cognitive or language barriers.
Data sourced from ClinicalTrials.gov (NCT01791803). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.